Picture of Hexo logo

HEXO Hexo Income Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Annual income statement for Hexo, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.

2018
July 31st
2019
July 31st
2020
July 31st
2021
July 31st
2022
July 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARS/AARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue4.9347.580.8124191
Cost of Revenue
Gross Profit2.8421.3-46.429.1-91.9
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses22.91356122091,259
Operating Profit-18-87-531-85.3-1,068
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-23.3-87.8-553-115-1,112
Provision for Income Taxes
Net Income After Taxes-23.3-69.6-546-115-1,074
Minority Interest
Net Income Before Extraordinary Items
Net Income-23.3-69.6-546-115-1,068
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-23.3-69.6-546-115-1,068
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-11.2-18.9-54.3-11-19.2